These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 5483970)

  • 1. Platelet adhesiveness, aggregation and fibrinolysis after the oral administration of the contraceptive "Lyndiol".
    Farbiszewski R; Kurowska T
    Thromb Diath Haemorrh; 1970 Oct; 24(1):304-7. PubMed ID: 5483970
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of lynestrenol (Lyndiol) as an oral contraceptive agent.
    Connell EB; Stone ML
    J Am Med Womens Assoc; 1967 Dec; 22(12):951-5. PubMed ID: 4230214
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet adhesiveness and lipoprotein lipase activity in controls and in subjects taking oral contraceptives.
    Ham JM; Rose R
    Am J Obstet Gynecol; 1969 Oct; 105(4):628-31. PubMed ID: 4898817
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a new combination oral contraceptive: lynestrenol-mestranol (Lyndiol).
    Moses LE; Goldzieher JW; Moses IG
    Fertil Steril; 1969; 20(5):715-28. PubMed ID: 5822858
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modification of the thrombocyte function using hormonal contraception. 1. Thrombocyte count, thrombocyte propagation and platelet aggregation under hormonal contraception].
    Traub RF; Brandt M; Hofmann KD
    Zentralbl Gynakol; 1976; 98(3):161-5. PubMed ID: 61668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Report on practical experiences with Lyndiol and Lyndiol 2.5].
    Falus M
    Med Welt; 1967 Dec; 50():3089-92. PubMed ID: 5610831
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormone excretion during and after treatment with Lyndiol 2.5].
    Keller M
    Gynaecologia; 1967; 163(4):187-98. PubMed ID: 6029674
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral contraceptives and platelet function.
    Mettler L; Selchow BM
    Thromb Diath Haemorrh; 1972 Oct; 28(2):213-20. PubMed ID: 4639655
    [No Abstract]   [Full Text] [Related]  

  • 9. [Change in calcium metabolism in women during prolonged treatment with 2,5 mg of Lyndiol].
    Chef R
    Bull Soc R Belge Gynecol Obstet; 1967; 37(4):255-63. PubMed ID: 5619668
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood platelet biochemistry in women receiving steroid contraceptives.
    Briggs M
    Haematologia (Budap); 1973; 7(3):347-67. PubMed ID: 4790074
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modification of the thrombocyte function using hormonal contraception. 2. Platelet adhesiveness, thromboelastography, conclusions].
    Brandt M; Traub RF; Hofmann KD
    Zentralbl Gynakol; 1976; 98(3):166-74. PubMed ID: 61669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet aggregation by adenosine diphosphoric acid in patients with liver cirrhosis. VI].
    Gandolfo GM
    Haematol Lat; 1970; 13(1):69-76. PubMed ID: 5506663
    [No Abstract]   [Full Text] [Related]  

  • 13. Absent plasma second phase platelet aggregation factor in a patient with Hageman trait.
    Okonkwo P; Post R; Sise H
    Thromb Diath Haemorrh; 1970 Jun; 23(3):423-31. PubMed ID: 5432187
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on liver factors which exert an inhibitory effect of platelet aggregation. The identification and characterization of platelet aggregation inhibitors from rabbit liver.
    Rogowski W; Galasiński W; Bańkowski E; Rzeczycki W
    Thromb Diath Haemorrh; 1971 Aug; 26(1):135-44. PubMed ID: 5112371
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of drugs on blood platelet characteristics].
    Zbinden G
    Schweiz Med Wochenschr; 1971 Nov; 101(46):1658-62. PubMed ID: 5140632
    [No Abstract]   [Full Text] [Related]  

  • 16. A new oral contraceptive with a 7 plus 15 sequential formulation.
    Brosens I; Van Assche A; Wijnants P
    Arzneimittelforschung; 1970 Feb; 20(2):236-7. PubMed ID: 5467468
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of platelet aggregation by dialysable fibrinogen degradation products (FDP).
    Stachurska J; Latallo Z; Kopeć M
    Thromb Diath Haemorrh; 1970 Feb; 23(1):91-8. PubMed ID: 5420436
    [No Abstract]   [Full Text] [Related]  

  • 18. [Side effects of the oral contraceptive Ovosiston on the blood coagulation system].
    Carol W; Klinger G; Hempel E; Starker K; Quent P
    Zentralbl Gynakol; 1970 Dec; 92(50):1641-50. PubMed ID: 4099364
    [No Abstract]   [Full Text] [Related]  

  • 19. Ovanon. A new sequential oral contraceptive.
    Rice-Wray E; Peña A; Maqueo M
    Int J Fertil; 1968; 13(4):453-9. PubMed ID: 5700405
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of platelet retention in glass bead columns to the rate of aggregation with adenosine diphosphate and thrombin.
    Bloom AL; Evans EP
    J Clin Pathol; 1969 Sep; 22(5):560-2. PubMed ID: 5364441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.